4 articles | last updated: Jul 11 21:55:30
New research identifies a defect in immune cell regulation, offering potential targeted treatments for the autoimmune disease.
- Researchers found an imbalance in T cells, leading to excessive harmful cells and insufficient protective ones.
- The study highlights the role of the aryl hydrocarbon receptor (AHR) in regulating immune responses.
- Activating AHR could reprogram harmful cells to become protective, suggesting a new therapeutic strategy.
- Current treatments broadly suppress the immune system, while this approach targets specific disease-causing cells.
- Further research is needed to confirm the effectiveness and safety of AHR-targeting therapies in humans.
People, Places and Things In This Story
- systemic lupus erythematosus Disease
Categories:
- Health